Exploring the frequency of a TP53 polyadenylation signal variant in tumor DNA from patients diagnosed with lung adenocarcinomas, sarcomas and uterine leiomyomas.
Vieira IA, Viola GD, Pezzi EH, Kowalski TW, Fernandes BV, Andreis TF, Bom N, Sonnenstrahl G, Rocha YMA, Corrêa BDS, Donatti LM, Sant'Anna GDS, Corleta HVE, Brum IS, Rosset C, Vianna FSL, Macedo GS, Palmero EI, Ashton-Prolla P.
Vieira IA, et al. Among authors: viola gd.
Genet Mol Biol. 2024 Jan 19;46(3 Suppl 1):e20230133. doi: 10.1590/1678-4685-GMB-2023-0133. eCollection 2024.
Genet Mol Biol. 2024.
PMID: 38252059
Free PMC article.